https://www.selleckchem.com/products/at13387.html
Our results provide novel advantages of phage therapy and phage-antibiotic therapy to control antibiotic-resistant bacteria.Coronavirus disease 2019 (COVID‐19) could lead to a sharp increase in the levels of inflammatory cytokines. We report the efficacy of therapeutic plasma exchange in severe COVID‐19 patients with acute respiratory distress syndrome. The results suggested TPE could be used as a strategy to attenuate circulating cytokines and inflammatory mediators.The publication entitled "Chilblains-like lesions in children followin
Like
Comment
Share
